FDA Approves Immunotherapy for dMMR Endometrial Cancer
Jemperli approved for dMMR endometrial cancer that progressed after platinum-containing chemotherapy treatment
Sacituzumab Govitecan Treats Metastatic Triple-Negative Breast Cancer
Progression-free, overall survival prolonged with sacitizumab govitecan versus single-agent chemotherapy
Survivors of Adolescent, Young Adult Cancer Face Financial Hardships
Hardships include forgoing care and medication nonadherence due to cost
Margin-Positive Surgery Still Beneficial in Pancreatic Cancer
Survival benefit seen for surgery, even with R1/R2 resection margins compared with chemotherapy alone for stage II pancreatic cancer
Mechanism ID’d for Thrombosis After ChAdOx1 nCoV-19 Vaccine
Testing for antibodies to platelet factor 4 positive in 22 of 23 patients; treatment with platelet transfusion should be avoided
Surgical Technique May Cut Positive Margin Rates in DCIS
Cavity shave margin resections for pure ductal carcinoma in situ may lower risk for positive margins
Timing of Chemotherapy for Glioblastoma May Matter
Treatment in the morning may be more effective, with greater impact seen in MGMT-methylated patients
Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
FDA granted Opdivo first approval of immunotherapy for first-line treatment of advanced or metastatic gastric cancer
Proportion of Black Physicians Has Changed Little Since 1900
Racial income differences were statistically significant each survey year, with difference of $50,000 in 2018
